ACADIA Pharmaceuticals unveils new Rett Syndrome research at Baltimore genetics meeting

ACADIA Pharmaceuticals unveils new Rett Syndrome research at Baltimore genetics meeting
ACADIA targets Rett Syndrome advances

ACADIA Pharmaceuticals has announced the presentation of its latest research developments on Rett Syndrome at the Annual Clinical Genetics Meeting taking place this week in Baltimore.

Attendees are invited to visit ACADIA Pharmaceuticals at booths 1531 and 1717 to learn more about current R&D progress in tackling Rett Syndrome, as the event brings together top experts in genetics and rare disease research.

ACADIA’s active engagement at the Annual Clinical Genetics Meeting builds on its ongoing commitments highlighted during earlier industry gatherings. Additional context on ACADIA Pharmaceuticals’ strategic presence in Baltimore can be found in the coverage of its plans to exhibit at the ACMG event with dedicated booths for attendees, as detailed in the article on the company's involvement at the genetics conference.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.
Weekly Top Bonuses
up to $2,500
deposit bonus for all clients
CLAIM BONUS
Your capital is at risk.